These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32176556)

  • 1. Personalized medicine in rheumatic diseases: how close are we to being able to use genetic biomarkers to predict response to TNF inhibitors?
    Sutcliffe M; Radley G; Barton A
    Expert Rev Clin Immunol; 2020 Apr; 16(4):389-396. PubMed ID: 32176556
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics: implications for therapy in rheumatic diseases.
    Davila L; Ranganathan P
    Nat Rev Rheumatol; 2011 Aug; 7(9):537-50. PubMed ID: 21826093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
    Bodio C; Grossi C; Pregnolato F; Favalli EG; Biggioggero M; Marchesoni A; Murgo A; Filippini M; Migliorini P; Caporali R; Pellerito R; Ciccia F; Sarzi-Puttini P; Perosa F; Paolazzi G; Hollan I; Bendtzen K; Meroni PL; Borghi MO
    Autoimmun Rev; 2020 May; 19(5):102509. PubMed ID: 32173513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Personalized medicine in cytokine-targeted therapy].
    Behrens F; Köhm M
    Z Rheumatol; 2013 Feb; 72(1):41-8. PubMed ID: 23392600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-tailored therapy in rheumatoid arthritis: an editorial review.
    Scherer HU; Dörner T; Burmester GR
    Curr Opin Rheumatol; 2010 May; 22(3):237-45. PubMed ID: 20177384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
    Umićević Mirkov M; Coenen MJ
    Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personalized medicine for rheumatoid arthritis : serological and clinical patient profiles to optimize B and T cell targeted therapy].
    Feist E; Dörner T
    Z Rheumatol; 2013 Feb; 72(1):49-58. PubMed ID: 23223871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis.
    Mok CC; Tsai WC; Chen DY; Wei JC
    Expert Opin Biol Ther; 2016; 16(2):201-11. PubMed ID: 26560845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.
    Chiu YM; Chen DY
    Expert Rev Clin Immunol; 2020 Feb; 16(2):207-228. PubMed ID: 31852268
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis.
    Guo X; Wang S; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Int J Rheum Dis; 2019 Apr; 22(4):646-653. PubMed ID: 30358109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review.
    Matucci A; Cammelli D; Cantini F; Goletti D; Marino V; Milano GM; Scarpa R; Tocci G; Maggi E; Vultaggio A
    Expert Opin Drug Saf; 2016 Dec; 15(sup1):3-10. PubMed ID: 27924646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases.
    Etminan M; Sodhi M; Samii A; Carleton BC; Kezouh A; Antonio Avina-Zubieta J
    Semin Arthritis Rheum; 2019 Jun; 48(6):1083-1086. PubMed ID: 30337056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature.
    Ingegnoli F; Favalli EG; Meroni PL
    Autoimmun Rev; 2011 Jun; 10(8):460-3. PubMed ID: 21296193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis.
    Miyagawa I; Tanaka Y
    Expert Rev Clin Immunol; 2020 Feb; 16(2):199-206. PubMed ID: 31905298
    [No Abstract]   [Full Text] [Related]  

  • 17. Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis.
    Nguyen MVC; Baillet A; Romand X; Trocmé C; Courtier A; Marotte H; Thomas T; Soubrier M; Miossec P; Tébib J; Grange L; Toussaint B; Lequerré T; Vittecoq O; Gaudin P
    Joint Bone Spine; 2019 Mar; 86(2):195-201. PubMed ID: 29885551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine in rheumatoid arthritis: hopes and challenges.
    Bridges SL
    Bull NYU Hosp Jt Dis; 2007; 65(3):174-7. PubMed ID: 17922665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world.
    Sung YK; Jung SY; Kim H; Choi S; Im SG; Lee YS; Jang EJ; Cho SK
    PLoS One; 2020; 15(1):e0227960. PubMed ID: 31978121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response to TNF inhibitors in rheumatoid arthritis - do we have new tools for personalized medicine?
    Simsek I
    Bull NYU Hosp Jt Dis; 2012; 70(3):187-90. PubMed ID: 23259626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.